A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...

“It’s a novel vaccine platform. It has not been explored in great ... such as transport to the nucleus and transcription into RNA. “With RNA, it just ...

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...

The team’s RNA-LNP approach – described in the journal Cell – works by reprogramming the TME using a sample of the tumour itself, so it can work both as a vaccine to stimulate an immune ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional CD8 + T cells in patients with pancreatic ductal adenocarcinoma (PDAC ...

The bill contains several misconceptions about mRNA vaccines, such as the false idea that the RNA can integrate into ... help of an enzyme called reverse transcriptase. Since this is not present ...

Developing messenger RNA vaccines such as the Pfizer-BioNTech and Moderna candidates has been fast because scientists were able to start their work before there was a known case of the novel ...

Scientists outside the vaccine manufacturing field frequently use sequencing to analyze aspects of DNA and RNA biology, including gene expression, RNA polyadenylation or poly(A) tails, and ...

As a now-proven vaccine technology ... best-in-class RNA polymerases for mRNA synthesis by in vitro transcription (IVT) (Fig. 1). Primrose Bio’s Prima RNApols offer significantly higher mRNA ...